Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement
The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus–positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein re...
Gespeichert in:
| Veröffentlicht in: | The Journal of heart and lung transplantation 2020-05, Vol.39 (5), p.418-432 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 432 |
|---|---|
| container_issue | 5 |
| container_start_page | 418 |
| container_title | The Journal of heart and lung transplantation |
| container_volume | 39 |
| creator | Aslam, Saima Grossi, Paolo Schlendorf, Kelly H. Holm, Are M. Woolley, Ann E. Blumberg, Emily Mehra, Mandeep R. Mehra, Mandeep R. Silveira, Fernanda P. Teuteberg, Jeffrey Crespo, Maria Lyster, Haifa Lourenco, Laura Machado, Sara Shullo, Michael Hartwig, Matthew Peraskeva, Miranda Wolfe, Cameron Khush, Kiran Ison, Michael Hall, Shelley Mooney, Joshua Ivulich, Steve Cypel, Marcelo Pretorius, Victor Uber, Patricia Kransdorf, Evan Cochrane, Adam Glanville, Alan Gray, Jennifer |
| description | The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus–positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years. |
| doi_str_mv | 10.1016/j.healun.2020.03.004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2398157670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1053249820314546</els_id><sourcerecordid>2398157670</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-35e3e719c3803c8a4027d2a8a9c0dc18179a886e782c7a13a8f6c1defa54c4253</originalsourceid><addsrcrecordid>eNp9kMtu1DAUhi0EoqXwBgh5ySbBlyR2WCBVI6CVRmJBu7aMfcJ4lLGDj1MVNvAOvCFPgssUlqzOv_jO7SPkOWctZ3x4tW93YOc1toIJ1jLZMtY9IKe871UjOVcPa2a9bEQ36hPyBHHPGBOyF4_JiRRyEHKUp-T7dQlz-GZLSJGmie5gqbkEpBt6E_KKv378DHECV8DTlD_bSH2KKSMNkTqbfUhll7J1wdGSbcRltrH8Gfeankd6-fFie0XhdoFcqEsRIeKKFCsCB4jlKXk02Rnh2X09I9fv3l5tLprth_eXm_Nt4-qlpZE9SFB8dFIz6bTtmFBeWG1Hx7zjmqvRaj2A0sIpy6XV0-C4h8n2netEL8_Iy-PcJacvK2Axh4AO5notpBVNtaF5rwbFKtodUZcTYobJLDkcbP5qODN36s3eHNWbO_WGSVPV17YX9xvWTwfw_5r-uq7AmyMA9c-bANmgCxAd-JCrX-NT-P-G3wWvmiE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2398157670</pqid></control><display><type>article</type><title>Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Aslam, Saima ; Grossi, Paolo ; Schlendorf, Kelly H. ; Holm, Are M. ; Woolley, Ann E. ; Blumberg, Emily ; Mehra, Mandeep R. ; Mehra, Mandeep R. ; Silveira, Fernanda P. ; Teuteberg, Jeffrey ; Crespo, Maria ; Lyster, Haifa ; Lourenco, Laura ; Machado, Sara ; Shullo, Michael ; Hartwig, Matthew ; Peraskeva, Miranda ; Wolfe, Cameron ; Khush, Kiran ; Ison, Michael ; Hall, Shelley ; Mooney, Joshua ; Ivulich, Steve ; Cypel, Marcelo ; Pretorius, Victor ; Uber, Patricia ; Kransdorf, Evan ; Cochrane, Adam ; Glanville, Alan ; Gray, Jennifer</creator><creatorcontrib>Aslam, Saima ; Grossi, Paolo ; Schlendorf, Kelly H. ; Holm, Are M. ; Woolley, Ann E. ; Blumberg, Emily ; Mehra, Mandeep R. ; Mehra, Mandeep R. ; Silveira, Fernanda P. ; Teuteberg, Jeffrey ; Crespo, Maria ; Lyster, Haifa ; Lourenco, Laura ; Machado, Sara ; Shullo, Michael ; Hartwig, Matthew ; Peraskeva, Miranda ; Wolfe, Cameron ; Khush, Kiran ; Ison, Michael ; Hall, Shelley ; Mooney, Joshua ; Ivulich, Steve ; Cypel, Marcelo ; Pretorius, Victor ; Uber, Patricia ; Kransdorf, Evan ; Cochrane, Adam ; Glanville, Alan ; Gray, Jennifer ; working group members</creatorcontrib><description>The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus–positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years.</description><identifier>ISSN: 1053-2498</identifier><identifier>EISSN: 1557-3117</identifier><identifier>DOI: 10.1016/j.healun.2020.03.004</identifier><identifier>PMID: 32362393</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antiviral Agents - therapeutic use ; Consensus ; donor ; HCV ; HCV+ cardiothoracic transplant ; HCV+ transplant ; Hepatitis C - virology ; hepatitis C virus ; Humans ; Organ Transplantation - methods ; Tissue Donors</subject><ispartof>The Journal of heart and lung transplantation, 2020-05, Vol.39 (5), p.418-432</ispartof><rights>2020 International Society for Heart and Lung Transplantation</rights><rights>Copyright © 2020 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-35e3e719c3803c8a4027d2a8a9c0dc18179a886e782c7a13a8f6c1defa54c4253</citedby><cites>FETCH-LOGICAL-c362t-35e3e719c3803c8a4027d2a8a9c0dc18179a886e782c7a13a8f6c1defa54c4253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1053249820314546$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32362393$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aslam, Saima</creatorcontrib><creatorcontrib>Grossi, Paolo</creatorcontrib><creatorcontrib>Schlendorf, Kelly H.</creatorcontrib><creatorcontrib>Holm, Are M.</creatorcontrib><creatorcontrib>Woolley, Ann E.</creatorcontrib><creatorcontrib>Blumberg, Emily</creatorcontrib><creatorcontrib>Mehra, Mandeep R.</creatorcontrib><creatorcontrib>Mehra, Mandeep R.</creatorcontrib><creatorcontrib>Silveira, Fernanda P.</creatorcontrib><creatorcontrib>Teuteberg, Jeffrey</creatorcontrib><creatorcontrib>Crespo, Maria</creatorcontrib><creatorcontrib>Lyster, Haifa</creatorcontrib><creatorcontrib>Lourenco, Laura</creatorcontrib><creatorcontrib>Machado, Sara</creatorcontrib><creatorcontrib>Shullo, Michael</creatorcontrib><creatorcontrib>Hartwig, Matthew</creatorcontrib><creatorcontrib>Peraskeva, Miranda</creatorcontrib><creatorcontrib>Wolfe, Cameron</creatorcontrib><creatorcontrib>Khush, Kiran</creatorcontrib><creatorcontrib>Ison, Michael</creatorcontrib><creatorcontrib>Hall, Shelley</creatorcontrib><creatorcontrib>Mooney, Joshua</creatorcontrib><creatorcontrib>Ivulich, Steve</creatorcontrib><creatorcontrib>Cypel, Marcelo</creatorcontrib><creatorcontrib>Pretorius, Victor</creatorcontrib><creatorcontrib>Uber, Patricia</creatorcontrib><creatorcontrib>Kransdorf, Evan</creatorcontrib><creatorcontrib>Cochrane, Adam</creatorcontrib><creatorcontrib>Glanville, Alan</creatorcontrib><creatorcontrib>Gray, Jennifer</creatorcontrib><creatorcontrib>working group members</creatorcontrib><title>Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement</title><title>The Journal of heart and lung transplantation</title><addtitle>J Heart Lung Transplant</addtitle><description>The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus–positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years.</description><subject>Antiviral Agents - therapeutic use</subject><subject>Consensus</subject><subject>donor</subject><subject>HCV</subject><subject>HCV+ cardiothoracic transplant</subject><subject>HCV+ transplant</subject><subject>Hepatitis C - virology</subject><subject>hepatitis C virus</subject><subject>Humans</subject><subject>Organ Transplantation - methods</subject><subject>Tissue Donors</subject><issn>1053-2498</issn><issn>1557-3117</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtu1DAUhi0EoqXwBgh5ySbBlyR2WCBVI6CVRmJBu7aMfcJ4lLGDj1MVNvAOvCFPgssUlqzOv_jO7SPkOWctZ3x4tW93YOc1toIJ1jLZMtY9IKe871UjOVcPa2a9bEQ36hPyBHHPGBOyF4_JiRRyEHKUp-T7dQlz-GZLSJGmie5gqbkEpBt6E_KKv378DHECV8DTlD_bSH2KKSMNkTqbfUhll7J1wdGSbcRltrH8Gfeankd6-fFie0XhdoFcqEsRIeKKFCsCB4jlKXk02Rnh2X09I9fv3l5tLprth_eXm_Nt4-qlpZE9SFB8dFIz6bTtmFBeWG1Hx7zjmqvRaj2A0sIpy6XV0-C4h8n2netEL8_Iy-PcJacvK2Axh4AO5notpBVNtaF5rwbFKtodUZcTYobJLDkcbP5qODN36s3eHNWbO_WGSVPV17YX9xvWTwfw_5r-uq7AmyMA9c-bANmgCxAd-JCrX-NT-P-G3wWvmiE</recordid><startdate>202005</startdate><enddate>202005</enddate><creator>Aslam, Saima</creator><creator>Grossi, Paolo</creator><creator>Schlendorf, Kelly H.</creator><creator>Holm, Are M.</creator><creator>Woolley, Ann E.</creator><creator>Blumberg, Emily</creator><creator>Mehra, Mandeep R.</creator><creator>Mehra, Mandeep R.</creator><creator>Silveira, Fernanda P.</creator><creator>Teuteberg, Jeffrey</creator><creator>Crespo, Maria</creator><creator>Lyster, Haifa</creator><creator>Lourenco, Laura</creator><creator>Machado, Sara</creator><creator>Shullo, Michael</creator><creator>Hartwig, Matthew</creator><creator>Peraskeva, Miranda</creator><creator>Wolfe, Cameron</creator><creator>Khush, Kiran</creator><creator>Ison, Michael</creator><creator>Hall, Shelley</creator><creator>Mooney, Joshua</creator><creator>Ivulich, Steve</creator><creator>Cypel, Marcelo</creator><creator>Pretorius, Victor</creator><creator>Uber, Patricia</creator><creator>Kransdorf, Evan</creator><creator>Cochrane, Adam</creator><creator>Glanville, Alan</creator><creator>Gray, Jennifer</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202005</creationdate><title>Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement</title><author>Aslam, Saima ; Grossi, Paolo ; Schlendorf, Kelly H. ; Holm, Are M. ; Woolley, Ann E. ; Blumberg, Emily ; Mehra, Mandeep R. ; Mehra, Mandeep R. ; Silveira, Fernanda P. ; Teuteberg, Jeffrey ; Crespo, Maria ; Lyster, Haifa ; Lourenco, Laura ; Machado, Sara ; Shullo, Michael ; Hartwig, Matthew ; Peraskeva, Miranda ; Wolfe, Cameron ; Khush, Kiran ; Ison, Michael ; Hall, Shelley ; Mooney, Joshua ; Ivulich, Steve ; Cypel, Marcelo ; Pretorius, Victor ; Uber, Patricia ; Kransdorf, Evan ; Cochrane, Adam ; Glanville, Alan ; Gray, Jennifer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-35e3e719c3803c8a4027d2a8a9c0dc18179a886e782c7a13a8f6c1defa54c4253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antiviral Agents - therapeutic use</topic><topic>Consensus</topic><topic>donor</topic><topic>HCV</topic><topic>HCV+ cardiothoracic transplant</topic><topic>HCV+ transplant</topic><topic>Hepatitis C - virology</topic><topic>hepatitis C virus</topic><topic>Humans</topic><topic>Organ Transplantation - methods</topic><topic>Tissue Donors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aslam, Saima</creatorcontrib><creatorcontrib>Grossi, Paolo</creatorcontrib><creatorcontrib>Schlendorf, Kelly H.</creatorcontrib><creatorcontrib>Holm, Are M.</creatorcontrib><creatorcontrib>Woolley, Ann E.</creatorcontrib><creatorcontrib>Blumberg, Emily</creatorcontrib><creatorcontrib>Mehra, Mandeep R.</creatorcontrib><creatorcontrib>Mehra, Mandeep R.</creatorcontrib><creatorcontrib>Silveira, Fernanda P.</creatorcontrib><creatorcontrib>Teuteberg, Jeffrey</creatorcontrib><creatorcontrib>Crespo, Maria</creatorcontrib><creatorcontrib>Lyster, Haifa</creatorcontrib><creatorcontrib>Lourenco, Laura</creatorcontrib><creatorcontrib>Machado, Sara</creatorcontrib><creatorcontrib>Shullo, Michael</creatorcontrib><creatorcontrib>Hartwig, Matthew</creatorcontrib><creatorcontrib>Peraskeva, Miranda</creatorcontrib><creatorcontrib>Wolfe, Cameron</creatorcontrib><creatorcontrib>Khush, Kiran</creatorcontrib><creatorcontrib>Ison, Michael</creatorcontrib><creatorcontrib>Hall, Shelley</creatorcontrib><creatorcontrib>Mooney, Joshua</creatorcontrib><creatorcontrib>Ivulich, Steve</creatorcontrib><creatorcontrib>Cypel, Marcelo</creatorcontrib><creatorcontrib>Pretorius, Victor</creatorcontrib><creatorcontrib>Uber, Patricia</creatorcontrib><creatorcontrib>Kransdorf, Evan</creatorcontrib><creatorcontrib>Cochrane, Adam</creatorcontrib><creatorcontrib>Glanville, Alan</creatorcontrib><creatorcontrib>Gray, Jennifer</creatorcontrib><creatorcontrib>working group members</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of heart and lung transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aslam, Saima</au><au>Grossi, Paolo</au><au>Schlendorf, Kelly H.</au><au>Holm, Are M.</au><au>Woolley, Ann E.</au><au>Blumberg, Emily</au><au>Mehra, Mandeep R.</au><au>Mehra, Mandeep R.</au><au>Silveira, Fernanda P.</au><au>Teuteberg, Jeffrey</au><au>Crespo, Maria</au><au>Lyster, Haifa</au><au>Lourenco, Laura</au><au>Machado, Sara</au><au>Shullo, Michael</au><au>Hartwig, Matthew</au><au>Peraskeva, Miranda</au><au>Wolfe, Cameron</au><au>Khush, Kiran</au><au>Ison, Michael</au><au>Hall, Shelley</au><au>Mooney, Joshua</au><au>Ivulich, Steve</au><au>Cypel, Marcelo</au><au>Pretorius, Victor</au><au>Uber, Patricia</au><au>Kransdorf, Evan</au><au>Cochrane, Adam</au><au>Glanville, Alan</au><au>Gray, Jennifer</au><aucorp>working group members</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement</atitle><jtitle>The Journal of heart and lung transplantation</jtitle><addtitle>J Heart Lung Transplant</addtitle><date>2020-05</date><risdate>2020</risdate><volume>39</volume><issue>5</issue><spage>418</spage><epage>432</epage><pages>418-432</pages><issn>1053-2498</issn><eissn>1557-3117</eissn><abstract>The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus–positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32362393</pmid><doi>10.1016/j.healun.2020.03.004</doi><tpages>15</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1053-2498 |
| ispartof | The Journal of heart and lung transplantation, 2020-05, Vol.39 (5), p.418-432 |
| issn | 1053-2498 1557-3117 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2398157670 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Antiviral Agents - therapeutic use Consensus donor HCV HCV+ cardiothoracic transplant HCV+ transplant Hepatitis C - virology hepatitis C virus Humans Organ Transplantation - methods Tissue Donors |
| title | Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T20%3A04%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utilization%20of%20hepatitis%20C%20virus%E2%80%93infected%20organ%20donors%20in%20cardiothoracic%20transplantation:%20An%20ISHLT%20expert%20consensus%20statement&rft.jtitle=The%20Journal%20of%20heart%20and%20lung%20transplantation&rft.au=Aslam,%20Saima&rft.aucorp=working%20group%20members&rft.date=2020-05&rft.volume=39&rft.issue=5&rft.spage=418&rft.epage=432&rft.pages=418-432&rft.issn=1053-2498&rft.eissn=1557-3117&rft_id=info:doi/10.1016/j.healun.2020.03.004&rft_dat=%3Cproquest_cross%3E2398157670%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2398157670&rft_id=info:pmid/32362393&rft_els_id=S1053249820314546&rfr_iscdi=true |